Miremont-Salamé G - Search Results

1

Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study.

Bénard-Laribière A, Miremont-Salamé G, Pérault-Pochat MC, Noize P, Haramburu F; EMIR Study Group on behalf of the French network of pharmacovigilance centres. Bénard-Laribière A, et al. Fundam Clin Pharmacol. 2015 Feb;29(1):106-11. doi: 10.1111/fcp.12088. Epub 2014 Sep 25. Fundam Clin Pharmacol. 2015. PMID: 24990220

2

Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study.

Friis-Møller N, Thiébaut R, Reiss P, Weber R, Monforte AD, De Wit S, El-Sadr W, Fontas E, Worm S, Kirk O, Phillips A, Sabin CA, Lundgren JD, Law MG; DAD study group. Friis-Møller N, et al. Eur J Cardiovasc Prev Rehabil. 2010 Oct;17(5):491-501. doi: 10.1097/HJR.0b013e328336a150. Eur J Cardiovasc Prev Rehabil. 2010. PMID: 20543702

3

Good and bad drug prescription in pregnancy.

Haramburu F, Miremont-Salamé G, Moore N. Haramburu F, et al. Lancet. 2000 Nov 18;356(9243):1704. doi: 10.1016/S0140-6736(00)03202-5. Lancet. 2000. PMID: 11095256 No abstract available.

4

Symptomatic bone disorders in HIV-infected patients: incidence in the Aquitaine cohort (1999-2002).

Martin K, Lawson-Ayayi S, Miremont-Salamé G, Blaizeau MJ, Balestre E, Lacoste D, Ragnaud JM, Malvy D, Dupon M, Mercié P, Schaeverbeke T, Haramburu F, Dabis F; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine. Martin K, et al. HIV Med. 2004 Nov;5(6):421-6. doi: 10.1111/j.1468-1293.2004.00247.x. HIV Med. 2004. PMID: 15544694 Free article.

5

Agreement of expert judgment in causality assessment of adverse drug reactions.

Arimone Y, Bégaud B, Miremont-Salamé G, Fourrier-Réglat A, Moore N, Molimard M, Haramburu F. Arimone Y, et al. Eur J Clin Pharmacol. 2005 May;61(3):169-73. doi: 10.1007/s00228-004-0869-2. Epub 2005 Apr 13. Eur J Clin Pharmacol. 2005. PMID: 15827761

6

[Antidepressant adverse effects in the elderly: analysis of spontaneous reports in France].

Daurel-Receveur M, Miremont-Salamé G, Fourrier A, Auriche P, Moore N, Bégaud B, Haramburu F; le réseau des Centres de Pharmacovigilance. Daurel-Receveur M, et al. Therapie. 2005 Jan-Feb;60(1):61-5. doi: 10.2515/therapie:2005008. Therapie. 2005. PMID: 15929475 French.

7

Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001).

Thiessard F, Roux E, Miremont-Salamé G, Fourrier-Réglat A, Haramburu F, Tubert-Bitter P, Bégaud B. Thiessard F, et al. Drug Saf. 2005;28(8):731-40. doi: 10.2165/00002018-200528080-00007. Drug Saf. 2005. PMID: 16048358

8

Surveillance of adverse effects during a vaccination campaign against meningitis C.

Laribière A, Miremont-Salamé G, Reyre H, Abouelfath A, Liège L, Moore N, Haramburu F. Laribière A, et al. Eur J Clin Pharmacol. 2005 Dec;61(12):907-11. doi: 10.1007/s00228-005-0053-3. Epub 2005 Nov 18. Eur J Clin Pharmacol. 2005. PMID: 16328316

9

A new method for assessing drug causation provided agreement with experts' judgment.

Arimone Y, Bégaud B, Miremont-Salamé G, Fourrier-Réglat A, Molimard M, Moore N, Haramburu F. Arimone Y, et al. J Clin Epidemiol. 2006 Mar;59(3):308-14. doi: 10.1016/j.jclinepi.2005.08.012. J Clin Epidemiol. 2006. PMID: 16488362

10

[Psychiatric adverse effects of fluoroquinolone: review of cases from the French pharmacologic surveillance database].

Doussau de Bazignan A, Thiessard F, Miremont-Salamé G, Conri C, Haramburu F; Centres Régionaux de Pharmacovigilance. Doussau de Bazignan A, et al. Rev Med Interne. 2006 Jun;27(6):448-52. doi: 10.1016/j.revmed.2006.02.003. Epub 2006 Mar 9. Rev Med Interne. 2006. PMID: 16580096 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters